Title |
Efecto de la crisis económica sobre el consumo de psicofármacos en Asturias
|
---|---|
Published in |
Gaceta Sanitaria, November 2016
|
DOI | 10.1016/j.gaceta.2016.02.006 |
Pubmed ID | |
Authors |
María Luisa Nicieza-García, Julio C. Alonso-Lorenzo, Patricio Suárez-Gil, Natalia Rilla-Villar |
Abstract |
To assess whether the economic crisis of 2008 has changed the consumption of anxiolytics, hypnotics-sedatives and antidepressants in Asturias (Spain). We conducted a descriptive study of drug use from 2003 -2013. The defined daily doses of 1000 inhabitants per day (DHD) were calculated for anxiolytics, hypnotics-sedatives and antidepressants. Linear regression coefficients (b) of the DHD were obtained for the pre-crisis period (2003-2008) and the crisis period (2009-2013). The consumption of anxiolytics increased by 40.25%, that of hypnotics by 88.11% and that of antidepressants by 80.93%. For anxiolytics: b-(2003-2008)=4.38 DDI/year and b-(2009-2013)=1.08 DDI/year. For hypnotics-sedatives: b-(2003-2008)=2.30 DDI/year and b-(2009-2013)=0.40 DDI/year. For antidepressants: b-(2003-2008)=5.79 DDI/year and b-(2009-2013)=2.83 DDI/year. The rise in consumption of the three subgroups during the crisis period was lower than that of the pre-crisis period. This study does not confirm the influence of the economic crisis on the rise in consumption of these drugs. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 67% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 23 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 5 | 22% |
Student > Doctoral Student | 3 | 13% |
Student > Ph. D. Student | 3 | 13% |
Student > Master | 3 | 13% |
Researcher | 2 | 9% |
Other | 3 | 13% |
Unknown | 4 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 30% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 22% |
Business, Management and Accounting | 2 | 9% |
Psychology | 1 | 4% |
Nursing and Health Professions | 1 | 4% |
Other | 2 | 9% |
Unknown | 5 | 22% |